6 Best Peptides for Obesity
Six compounds show up consistently in research and real-world discussion for obesity, ranging from FDA-approved injectable drugs like semaglutide and tirzepatide to investigational options like retatrutide, which is generating serious clinical excitement in late-stage trials, to cagrilintide, mazdutide, and tesofensine, each representing a distinct mechanism or stage of development. The evidence base varies considerably across these six, from large replicated Phase 3 trials to Asian-market data to Phase 2 work, and that variation is described honestly in each entry rather than used to filter anyone off the list. The entries are ordered by how prominently each compound appears in clinical evidence and real-world use, not as a recommendation of one over another for any specific person.
